Navigation Links
A Unique Collaboration of Life Science Leaders, including the Fight Against Cancer Innovation Trust, MaRS Innovation Ventures Trust and MaRS Phase II Investment Trust, has formed Triphase Accelerator Corporation to be an Oncology Development Accele
Date:1/9/2014

TORONTO and SAN DIEGO, Jan. 9, 2014 /PRNewswire/ -- Triphase Accelerator Corporation was formed in 2010 as a cancer-focused biotechnology development company whose aim is to reduce the time and expense between an Investigational New Drug application and "proof-of-concept" at Phase II. Triphase was spun out of the Ontario Institute for Cancer Research (OICR) to develop and advance late pre-clinical, Phase I or early Phase II potential products. Triphase and its founding investors are in a position to take advantage of the excellent research and development capabilities in the Toronto healthcare and innovation ecosystem.  The Fight Against Cancer Innovation Trust (FACIT), MaRS Innovation Ventures Trust, and MaRS Phase II Investment Trust, are all Toronto based equity investors in Triphase.

After the formation of the company, Triphase entered into a strategic relationship with Celgene Corporation. Through this arrangement, Celgene obtained rights of first refusal on the first three oncology products Triphase advances to clinical proof-of-concept (POC), plus a right of first negotiation on three more future oncology products which may be acquired by Triphase. Following the acquisition by Triphase of its first oncology product in late 2012, the Triphase-Celgene collaboration was initiated, along with an undisclosed upfront payment.  Triphase controls the development of this first product from early clinical research to POC.  Upon achievement of POC, Celgene will have an exclusive option to acquire this product and, if such option is exercised, Triphase will be entitled to certain regulatory and commercial milestone payments. 

Triphase Founder, President and CEO Frank Stonebanks commented, "I am thrilled with the support by FACIT, MaRS Innovation Ventures Trust and MaRS Phase II Investment Trust to
'/>"/>

SOURCE Triphase
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Biocartis and VIB Join Forces to Develop Unique Diagnostic Cancer Test
2. Hummingbird metabolism unique in burning glucose and fructose equally
3. Medical Diagnostics Testing Industry Executives Reveal Unique Supply Chain Opportunities at BSMA Conference
4. Lung Institute Supports Pulmonary Fibrosis Awareness Day with Unique Plea to the Public
5. Human foot not as unique as originally thought
6. Syngenta Opens Unique $72 Million Advanced Crop Lab
7. InstantGMP Announces Release of Unique Electronic Batch Record Software as a Service for Just $99/mo
8. Dr. Vasquez at the Connecticut Plastic Surgery Group Now Offers the Unique Crisalix 3D Simulations for Facial Aesthetics and Breast Augmentation
9. Unique Extracellular Matrix Used in Patient Successfully Treated for Flesh Eating Bacteria
10. Biotrial, a Successful Leading CRO, Continues to Expand its Activities, Creating a Unique Neuroscience Pool of Talent and Capabilities: Biotrial Neuroscience
11. Marrone Bio Innovations Files Patent for a Unique Bacillus Species
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... have an advantage in the media. A new study ... published in the journal of Israel,s National Security College, ... this arena too. , "Information warfare" plays ... sometimes more so than conventional weapons. Therefore, the information ...
... discovered a way to use an ancient life form to ... systems that may be surprisingly simple to build compared to ... tiny, single-celled marine life forms have existed for at least ... the life in the oceans, but they also have rigid ...
... Inc. (Nasdaq: ANDS ) announced today that ... Thursday, April 23, 2009, after the U.S. financial markets ... Thursday, April 23, 2009 at 5:00 p.m. Eastern Daylight ... and highlights and to provide an update on its ...
Cached Biology Technology:Information warfare in the 21st century: Ideas are sometimes stronger than bombs 2Ancient diatoms lead to new technology for solar energy 2Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results 2
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... addition of the "Global Facial Recognition Market ... http://photos.prnewswire.com/prnh/20130307/600769 Facial ... of individuals. Facial recognition system measures the overall ... jaw edges, mouth, and the distance between eyes. ...
(Date:12/11/2014)... 10, 2014  Data Sciences International (DSI), the ... a new series of digital telemetry implants to ... M series, part of the PhysioTel™ Digital platform, ... possible physiologic data when incorporating functional endpoints into ... to toxicology studies has evolved from short ECG ...
(Date:12/10/2014)... 9, 2014 CIE San Diego has launched ... the connective tissue that enhances care coordination among social ... share client-level information; earned a second $1 million grant ... serving seniors aging in community and; will be recognized ... 11 th 4-6p. CIE San Diego ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... The GARBAN project, drawn up by Navarre University, will ... and hepatitis. , The School of Engineering at Navarre ... in Gipuzkoa (CEIT) have launched an advanced biochemical analysis ... diseases, accelerate their diagnosis and identify new therapeutic targets ...
... long time that only 2% -- 3% of human DNA ... -- often referred to as junk DNA -- consists of ... DNA, and then reinserted into a new spot in the ... retroelements. Retroviruses can insinuate themselves into the host's DNA in ...
... magnetic "nanoparticles" to DNA and then cut these "DNA ... self-assembling devices for future computers. , Findings are detailed ... Journal of the American Chemical Society. The paper was ... Albena Ivanisevic, an assistant professor of biomedical engineering and ...
Cached Biology News:Analysis Of Human Genome To Predict The Development Of Illnesses 2Chimp genome reveals a retroviral invasion 2Chimp genome reveals a retroviral invasion 3Purdue researchers use enzyme to clip 'DNA wires' 2Purdue researchers use enzyme to clip 'DNA wires' 3
Request Info...
...
... potent inhibition of RNase A-type ribonucleases Product ... of nonhuman origin that binds noncovalently and ... A, B, and C). It does not ... U2, or CL3. QIAGEN RNase Inhibitor inhibits ...
Request Info...
Biology Products: